Tipranavir: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) Blanked the page |
Ahmed Zaghw (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Tipranavir}} | |||
{{CMG}} | |||
==Overview== | |||
==Category== | |||
==US Brand Names== | |||
Aptivus<sup>®</sup> | |||
==FDA Package Insert== | |||
''' [[Tipranavir description|Description]]''' | |||
'''| [[Tipranavir clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Tipranavir microbiology|Microbiology]]''' | |||
'''| [[Tipranavir indications and usage|Indications and Usage]]''' | |||
'''| [[Tipranavir contraindications|Contraindications]]''' | |||
'''| [[Tipranavir warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Tipranavir adverse reactions|Adverse Reactions]]''' | |||
'''| [[Tipranavir drug interactions|Drug Interactions]]''' | |||
'''| [[Tipranavir overdosage|Overdosage]]''' | |||
'''| [[Tipranavir clinical studies|Clinical Studies]]''' | |||
'''| [[Tipranavir dosage and administration|Dosage and Administration]]''' | |||
'''| [[Tipranavir how supplied|How Supplied]]''' | |||
'''| [[Tipranavir labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] | |||
Revision as of 14:50, 2 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Category
US Brand Names
Aptivus®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages